Oncology Medical Director – Global Clinical Development (Remote)

MENARINI Group; New York (NY); Remote; USD 280,000 - 350,000; Full time

Job summary

Menarini Stemline seeks a Senior Medical Director, Clinical Development in solid tumours to shape global oncology programs from first-in-human to registration. You will lead cross-functional teams, design protocols, monitor safety, and drive regulatory submissions with CRO partners.

Remote role with ~20% travel; NY-based tax considerations apply. Base salary range of $280,000–$350,000 with comprehensive benefits and a strong focus on oncology innovation.

Qualifications

• Medical Degree with 5+ years pharma/biotech experience, board certified oncology preferred.
• Experience developing clinical strategy for oncology (Phase I-III) leading to regulatory submissions.
• Breast Cancer training/experience required/beneficial.
• Expertise in clinical trials, literature reviews, publications.
• Knowledge of GCP, ICH, FDA, EMEA regulations.

Responsibilities

• Represent clinical science on global programs and contribute to strategy.
• Lead development of clinical study protocols and related documents.
• Medical monitoring and data interpretation for safety signals.
• Communicate results across reports and regulatory submissions.
• Support site training, initiation, activation and site engagement.

Skills

Clinical leadership

Cross-functional teamwork

Regulatory submissions

Scientific writing

Communication skills

KOL engagement

Data interpretation

Strategic planning

Project management

Education

Medical Degree

Board-certified Oncology

Breast Cancer training/experience

Job description

Menarini Stemline seeks a Senior Medical Director, Clinical Development in solid tumours to shape global oncology programs from first-in-human to registration. You will lead cross-functional teams, design protocols, monitor safety, and drive regulatory submissions with CRO partners.

Remote role with ~20% travel; NY-based tax considerations apply. Base salary range of $280,000–$350,000 with comprehensive benefits and a strong focus on oncology innovation.